Catalyst Pharmaceuticals
CPRX
#3844
Rank
HK$19.71 B
Marketcap
HK$165.27
Share price
-0.89%
Change (1 day)
31.69%
Change (1 year)

Earnings for Catalyst Pharmaceuticals (CPRX)

Earnings in 2024 (TTM): HK$1.47 Billion

According to Catalyst Pharmaceuticals's latest financial reports the company's current earnings are HK$0.46 Billion. In 2023 the company made an earning of HK$0.73 Billion a decrease over its 2022 earnings that were of HK$0.81 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Catalyst Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$1.47 B100.56%
2023 HK$0.73 B-9.75%
2022 HK$0.81 B98.83%
2021 HK$0.40 B25.73%
2020 HK$0.32 B25.38%
2019 HK$0.25 B-198.25%
2018 -HK$0.27 Billion84.68%
2017 -HK$0.15 Billion1.88%
2016 -HK$0.15 Billion-10.68%
2015 -HK$0.16 Billion30.46%
2014 -HK$0.13 Billion27.6%
2013 -HK$94.45 Million198.17%
2012 -HK$31.68 Million-36.22%
2011 -HK$49.66 Million59.52%
2010 -HK$31.13 Million-44.68%
2009 -HK$56.27 Million-31.45%
2008 -HK$82.09 Million155.21%
2007 -HK$32.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$3.04 B 107.35%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.00 B-31.46%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$142.92 B 9,643.68%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$2.12 Billion-243.96%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$53.94 B 3,577.65%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$52.66 B 3,490.25%๐Ÿ‡บ๐Ÿ‡ธ USA